{"id":"https://openalex.org/W2087340871","doi":"https://doi.org/10.1097/01.ico.0000133993.14768.a9","title":"Double-Masked, Placebo-Controlled Safety and Efficacy Trial of Diquafosol Tetrasodium (INS365) Ophthalmic Solution for the Treatment of Dry Eye","display_name":"Double-Masked, Placebo-Controlled Safety and Efficacy Trial of Diquafosol Tetrasodium (INS365) Ophthalmic Solution for the Treatment of Dry Eye","alternate_titles":[],"publication_year":2004,"publication_date":"2004-10-21","ids":{"openalex":"https://openalex.org/W2087340871","doi":"https://doi.org/10.1097/01.ico.0000133993.14768.a9","mag":"2087340871","pmid":"https://pubmed.ncbi.nlm.nih.gov/15502479"},"language":"en","primary_location":{"id":"doi:10.1097/01.ico.0000133993.14768.a9","doi":"https://doi.org/10.1097/01.ico.0000133993.14768.a9","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ico.0000133993.14768.a9","pdf_url":null,"source":{"id":"https://openalex.org/S145806103","display_name":"Cornea","issn_l":"0277-3740","issn":["0277-3740","1536-4798"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cornea","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2087340871"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025291618","display_name":"Joseph Tauber","orcid":"https://orcid.org/0000-0001-5365-8795","observed_orcids":["https://orcid.org/0000-0001-5365-8795"]},"institutions":[{"id":"https://openalex.org/I4210142679","display_name":"Tauber Eye Center","ror":"https://ror.org/05525qx48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210142679"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"J Tauber","raw_affiliation_strings":["Tauber Eye Center, Kansas City, MO 64111, USA. jt@taubereye.com","Tauber Eye Center, Kansas City, MO 64111, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tauber Eye Center, Kansas City, MO 64111, USA. jt@taubereye.com","institution_ids":["https://openalex.org/I4210142679"]},{"raw_affiliation_string":"Tauber Eye Center, Kansas City, MO 64111, USA","institution_ids":["https://openalex.org/I4210142679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069526138","display_name":"William F. Davitt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W F Davitt","raw_affiliation_strings":["Corona Research, El Paso, TX","Corona Research Clinical Studies, El Paso, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corona Research, El Paso, TX","institution_ids":[]},{"raw_affiliation_string":"Corona Research Clinical Studies, El Paso, TX, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085663037","display_name":"John E. Bokosky","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J E Bokosky","raw_affiliation_strings":["Eye Care of San Diego, San Diego, CA","Eye Care of San Diego, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eye Care of San Diego, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Eye Care of San Diego, San Diego, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025768648","display_name":"Kelly K. Nichols","orcid":"https://orcid.org/0000-0003-2937-1457","observed_orcids":["https://orcid.org/0000-0003-2937-1457"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K K Nichols","raw_affiliation_strings":["Ohio State University, College of Optometry, Columbus, OH","Ohio State University College of Optometry, Columbus, OH, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ohio State University, College of Optometry, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]},{"raw_affiliation_string":"Ohio State University College of Optometry, Columbus, OH, United States","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023046405","display_name":"Benjamin R. Yerxa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B R Yerxa","raw_affiliation_strings":["Inspire Pharmaceuticals, Inc, Durham, NC","Inspire Pharmaceuticals, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inspire Pharmaceuticals, Inc, Durham, NC","institution_ids":[]},{"raw_affiliation_string":"Inspire Pharmaceuticals, Durham, NC, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053093524","display_name":"Amy E. Schaberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A E Schaberg","raw_affiliation_strings":["Inspire Pharmaceuticals, Inc, Durham, NC","Inspire Pharmaceuticals, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inspire Pharmaceuticals, Inc, Durham, NC","institution_ids":[]},{"raw_affiliation_string":"Inspire Pharmaceuticals, Durham, NC, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026070714","display_name":"Lisa Morrissey LaVange","orcid":"https://orcid.org/0000-0001-6755-6925","observed_orcids":["https://orcid.org/0000-0001-6755-6925"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L M LaVange","raw_affiliation_strings":["Inspire Pharmaceuticals, Inc, Durham, NC","Inspire Pharmaceuticals, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inspire Pharmaceuticals, Inc, Durham, NC","institution_ids":[]},{"raw_affiliation_string":"Inspire Pharmaceuticals, Durham, NC, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078662092","display_name":"M.C. Mills-Wilson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M C Mills-Wilson","raw_affiliation_strings":["Inspire Pharmaceuticals, Inc, Durham, NC","Inspire Pharmaceuticals, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inspire Pharmaceuticals, Inc, Durham, NC","institution_ids":[]},{"raw_affiliation_string":"Inspire Pharmaceuticals, Durham, NC, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107277988","display_name":"Donald J. Kellerman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D J Kellerman","raw_affiliation_strings":["Inspire Pharmaceuticals, Inc, Durham, NC","Maximum Likelihood Solutions, Chapel Hill, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inspire Pharmaceuticals, Inc, Durham, NC","institution_ids":[]},{"raw_affiliation_string":"Maximum Likelihood Solutions, Chapel Hill, NC, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5025291618"],"corresponding_institution_ids":["https://openalex.org/I4210142679"],"apc_list":null,"apc_paid":null,"fwci":6.1437,"has_fulltext":false,"cited_by_count":173,"citation_normalized_percentile":{"value":0.96279733,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"23","issue":"8","first_page":"784","last_page":"792"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11521","display_name":"Salivary Gland Disorders and Functions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dry-eye-disease","display_name":"dry eye","score":0.878000020980835},{"id":"https://openalex.org/keywords/ocular-surface","display_name":"ocular surface","score":0.6859999895095825},{"id":"https://openalex.org/keywords/corneal-staining","display_name":"corneal staining","score":0.8550000190734863},{"id":"https://openalex.org/keywords/conjunctival-staining","display_name":"conjunctival staining","score":0.9929999709129333},{"id":"https://openalex.org/keywords/schirmer-test","display_name":"Schirmer test","score":0.9520000219345093},{"id":"https://openalex.org/keywords/foreign-body-sensation","display_name":"foreign body sensation","score":0.8690000176429749},{"id":"https://openalex.org/keywords/mucin-secretion","display_name":"mucin secretion","score":0.7059999704360962},{"id":"https://openalex.org/keywords/topical-ophthalmic-solution","display_name":"topical ophthalmic solution","score":0.734000027179718},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.8190000057220459}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8304067254066467},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7046728134155273},{"id":"https://openalex.org/C2778837293","wikidata":"https://www.wikidata.org/wiki/Q3320636","display_name":"Artificial tears","level":2,"score":0.7001171112060547},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6141375303268433},{"id":"https://openalex.org/C74864618","wikidata":"https://www.wikidata.org/wiki/Q2332446","display_name":"Staining","level":2,"score":0.5419481992721558},{"id":"https://openalex.org/C2778275304","wikidata":"https://www.wikidata.org/wiki/Q76469","display_name":"Tears","level":2,"score":0.4124314785003662},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.20521998405456543},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11652892827987671},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003228","descriptor_name":"Conjunctiva","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003287","descriptor_name":"Contrast Media","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003315","descriptor_name":"Cornea","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011122","descriptor_name":"Polyphosphates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011122","descriptor_name":"Polyphosphates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011122","descriptor_name":"Polyphosphates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013194","descriptor_name":"Staining and Labeling","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D013666","descriptor_name":"Tears","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013666","descriptor_name":"Tears","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014500","descriptor_name":"Uracil Nucleotides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014500","descriptor_name":"Uracil Nucleotides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014500","descriptor_name":"Uracil Nucleotides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015352","descriptor_name":"Dry Eye Syndromes","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D015352","descriptor_name":"Dry Eye Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015352","descriptor_name":"Dry Eye Syndromes","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019793","descriptor_name":"Fluorescein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058910","descriptor_name":"Purinergic P2 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.ico.0000133993.14768.a9","doi":"https://doi.org/10.1097/01.ico.0000133993.14768.a9","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ico.0000133993.14768.a9","pdf_url":null,"source":{"id":"https://openalex.org/S145806103","display_name":"Cornea","issn_l":"0277-3740","issn":["0277-3740","1536-4798"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cornea","raw_type":"journal-article"},{"id":"pmid:15502479","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15502479","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cornea","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W35693665","https://openalex.org/W1191431061","https://openalex.org/W1498002377","https://openalex.org/W1523354060","https://openalex.org/W1530639720","https://openalex.org/W1651036320","https://openalex.org/W1976640360","https://openalex.org/W1978136073","https://openalex.org/W1981740138","https://openalex.org/W1983982734","https://openalex.org/W1984490871","https://openalex.org/W1986853457","https://openalex.org/W1988967364","https://openalex.org/W1994066422","https://openalex.org/W1996397549","https://openalex.org/W2008878337","https://openalex.org/W2017282855","https://openalex.org/W2028465131","https://openalex.org/W2032715345","https://openalex.org/W2048559625","https://openalex.org/W2072021875","https://openalex.org/W2115345791","https://openalex.org/W2133085450","https://openalex.org/W2138321161","https://openalex.org/W2147254926","https://openalex.org/W2184917771","https://openalex.org/W2319815993"],"related_works":["https://openalex.org/W1967987864","https://openalex.org/W247771020","https://openalex.org/W2025127211","https://openalex.org/W3204632183","https://openalex.org/W4240789390","https://openalex.org/W2032060118","https://openalex.org/W2140295765","https://openalex.org/W2063781348","https://openalex.org/W4206543284","https://openalex.org/W2030827155"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"investigate":[2],"the":[3,21,104,115,135,210],"safety":[4],"and":[5,17,58,72,111,138,231,245,255,277],"efficacy":[6,107],"of":[7,29,50,55,75,81,130,182,186,191,221,227,271,283],"diquafosol":[8,56,93,147,174,203,222],"tetrasodium,":[9],"a":[10,25,42,263,268,279],"P2Y2":[11],"receptor":[12],"agonist":[13],"that":[14],"stimulates":[15],"fluid":[16],"mucin":[18],"secretion":[19],"on":[20],"ocular":[22],"surface,":[23],"as":[24,86,124,126],"novel":[26,280],"topical":[27,281],"treatment":[28,51,148,175,282],"dry":[30,36,76,274,284],"eye":[31,37,77,275],"disease.":[32],"METHODS:":[33],"Subjects":[34,89],"with":[35,52,91,101,159,173,177,184,201,206,273],"(n=527)":[38],"were":[39,78,122,132,139,157,170,223],"evaluated":[40],"in":[41,119,198,219,235,251,256,267],"randomized,":[43],"double-masked,":[44],"parallel-group":[45],"trial":[46],"comparing":[47],"24":[48],"weeks":[49,129],"2":[53,128],"concentrations":[54],"(1%":[57],"2%)":[59],"versus":[60],"placebo":[61,102,178,207,249],"instilled":[62],"4":[63],"times":[64],"daily.":[65],"Corneal":[66],"staining,":[67,69],"conjunctival":[68,155],"Schirmer":[70,165],"tests,":[71],"subjective":[73],"symptoms":[74],"evaluated.":[79],"Use":[80],"artificial":[82],"tears":[83],"was":[84,149,193,242,246],"permitted":[85],"necessary.":[87],"RESULTS:":[88],"treated":[90,200],"2%":[92,202],"had":[94],"significantly":[95,171],"lower":[96],"corneal":[97,120,163,253],"staining":[98,121,156,254],"scores":[99,166],"compared":[100,205],"at":[103,167,195],"6-week,":[105],"primary":[106],"time":[108],"point":[109],"(P<0.001),":[110],"superiority":[112],"continued":[113],"throughout":[114,134],"24-week":[116,136],"study.":[117],"Reductions":[118],"observed":[123,140,161,224],"early":[125],"after":[127],"treatment,":[131],"maintained":[133],"study,":[137],"to":[141,248],"worsen":[142],"slightly":[143],"(toward":[144],"baseline)":[145],"when":[146],"discontinued":[150],"(week":[151],"25).":[152],"Results":[153],"for":[154,162,225,232],"consistent":[158],"those":[160],"staining.":[164],"week":[168,196],"6":[169,197],"higher":[172,194],"than":[176],"(P<or=0.030).":[179],"The":[180],"percentage":[181],"subjects":[183,199],"clearing":[185,226],"foreign":[187,228],"body":[188,229],"sensation":[189,230],"(score":[190],"0)":[192],"(21%)":[204],"(15%),":[208],"but":[209],"difference":[211],"did":[212],"not":[213],"achieve":[214],"significance":[215],"(P=0.193).":[216],"Significant":[217],"differences":[218],"favor":[220],"worst":[233],"symptom":[234],"secondary":[236],"data":[237],"analyses.":[238],"CONCLUSION:":[239],"Diquafosol":[240,261],"tetrasodium":[241],"well":[243],"tolerated":[244],"superior":[247],"(vehicle)":[250],"reducing":[252],"relieving":[257],"certain":[258],"patient":[259],"symptoms.":[260],"has":[262],"favorable":[264],"risk/benefit":[265],"profile":[266],"broad":[269],"spectrum":[270],"patients":[272],"disease":[276],"is":[278],"eye.":[285]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2087340871","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":20},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
